Neurovascular Care Leader CERENOVUS, a leader in neurovascular care, offers a broad portfolio of devices for hemorrhagic and ischemic stroke treatment, showcasing effectiveness in addressing critical medical needs.
Financially Solid With estimated revenue between $100M - 1B, CERENOVUS demonstrates financial strength, indicating potential for significant sales opportunities and investment partnerships.
Strategic Location Located in Irvine, California, a hub for medical technology companies, CERENOVUS benefits from a strategic position that provides access to a talent pool and industry collaborations, enhancing sales prospects.
Advanced Tech Integration Utilizing tech solutions like Google, AWS, and Zoom, CERENOVUS showcases a commitment to innovation, facilitating efficient operations, virtual sales interactions, and potential tech-driven market expansions.
Competitive Differentiation In a competitive landscape with companies like Medtronic and Stryker, CERENOVUS stands out through its focused neurovascular care approach, presenting distinct sales opportunities for specialized medical equipment.
251
$10M$50M
310$10M$50M
32$10M
93K$1B
36$10M
39
18K$1B
43K$1B
46K$1BCERENOVUS uses 6 technology products and services including Bitly, Google, Amazon Web Services, and more. Explore CERENOVUS's tech stack below.
| CERENOVUS Email Formats | Percentage |
| FLast@its.jnj.com | 62% |
| LFirst@its.jnj.com | 6% |
| First.Last@its.jnj.com | 5% |
| F-Last@its.jnj.com | 3% |
| FirstLast@its.jnj.com | 2% |
| FiLast@its.jnj.com | 1% |
| LastFir@its.jnj.com | 2% |
| LastFirst@its.jnj.com | 1% |
| First_Last@its.jnj.com | 1% |
| First-Last@its.jnj.com | 2% |
| Last.First@its.jnj.com | 1% |
| FirLast@its.jnj.com | 1% |
| Last_First@its.jnj.com | 1% |
| LastF@its.jnj.com | 2% |
| LastFi@its.jnj.com | 1% |
| FirstL@its.jnj.com | 1% |
| Last.F@its.jnj.com | 1% |
| F_Last@its.jnj.com | 1% |
| FirstLas@its.jnj.com | 1% |
| FMLast@its.jnj.com | 1% |
| FMiddleLast@its.jnj.com | 1% |
| FL@its.jnj.com | 1% |
| FirstMiddleLas@its.jnj.com | 1% |
| LF@its.jnj.com | 1% |
| LastF@bit.ly | 75% |
| First.Last@bit.ly | 18% |
| First@bit.ly | 6% |
| Last@bit.ly | 1% |
Medical Equipment ManufacturingCalifornia, United States501-1000 Employees
CERENOVUS, part of Johnson & Johnson MedTech, is an emerging leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke.
Company Overview
Funding & FinancialsCERENOVUS's revenue is in the range of $100M$1B
Funding & FinancialsCERENOVUS's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com